### Required reading

Chapter 5.

### Recommended reading <a name="recommended"></a>

Richard Feinman. Intention-to-treat. What is the question?. Nutrition & Metabolism. 2009;6(1):1. Available in [html format](https://nutritionandmetabolism.biomedcentral.com/articles/10.1186/1743-7075-6-1) and [PDF format](https://nutritionandmetabolism.biomedcentral.com/track/pdf/10.1186/1743-7075-6-1).

Steve Simon. StATS: Exlcuding placebo responders. P.Mean website, June 25, 2004. Available in [html format](http://www.pmean.com/04/placebo.html).

Steve Simon. StATS: So you want to volunteer for a research study? P.Mean website, August 4, 2004. Available in [html format] (http://www.pmean.com/04/volunteer.html).

Douglas G Altman, Kenneth F Schulz. Statistics Notes: Concealing treatment allocation in randomised trials. BMJ. 2001 Aug 25; 323(7310): 446-447. Avialble in [html format](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1121039/) or [PDF format](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1121039/pdf/446.pdf).

KP Suresh. An overview of randomization techniques: An unbiased assessment of outcome in clinical research. J Hum Reprod Sci. 2011 Jan-Apr; 4(1): 8-11. doi: 10.4103/0974-1208.82352. Available in [html format](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136079/).

Harford T. The random risks of randomised trials. Financial Times, April 25, 2014. Available in [html format](http://www.ft.com/intl/cms/s/2/59bb202c-ca7b-11e3-8a31-00144feabdc0.html#axzz30BOFBYb7).

Steve Simon.  StATS: Is the randomized trial the gold standard for research? P.Mean website, September 23, 2004. Available in [html format](http://www.pmean.com/04/GoldStandard.html).

Kenneth F Schulz, David A Grimes. Blinding in randomised trials: hiding who got what. The Lancet
Volume 359, Issue 9307, 23 February 2002, Pages 696-700. Available, but [behind a paywall](https://doi.org/10.1016/S0140-6736(02)07816-9).

Steve Simon. StATS: Ethics of a placebo group. P.Mean website, August 2, 2001. Available in [html format](http://www.pmean.com/01/placebo.html)

Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med. 2001 May 24;344(21):1594-602. Review. Available in [html foramt](https://www.nejm.org/doi/10.1056/NEJM200105243442106) or [PDF format](https://www.nejm.org/doi/pdf/10.1056/NEJM200105243442106)

Farnham Street. Regression Toward the Mean: An Introduction with Examples. Available in [html format](https://fs.blog/2015/07/regression-to-the-mean/).

James Penston. Large-scale randomised trials - a misguided approach to clinical research. Medical Hypotheses (2005) 64, 651-657. Available, but [behind a pay wall](https://www.sciencedirect.com/science/article/pii/S0306987704005183).

Rebecca A. Clay. More than one way to measure: Randomized clinical trials have their place, but critics argue that researchers would get better results if they also embraced other methodologies. Monior on Psychology. September 2010, 41(8): 52. Available in [html format](https://www.apa.org/monitor/2010/09/trials).

Laura Rosen, Orly Manor, Dan Engelhard, and David Zucker. In Defense of the Randomized Controlled Trial for Health Promotion Research. Am J Public Health. 2006 July; 96(7): 1181-1186. doi: 10.2105/AJPH.2004.061713. Avialbe in [html format](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483860/) or [PDF format](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483860/pdf/0961181.pdf).

Niemansburg SL, van Delden JJM, Dhert WJA, Bredenoord AL. Reconsidering the ethics of sham interventions in an era of emerging technologies. Surgery 2015-04-01. 157(4): P801-810. DOI: 10.1016/j.surg.2014.12.001. Available in [html format](https://www.surgjournal.com/article/S0039-6060(14)00786-7/fulltext) or [pdf format](https://www.surgjournal.com/action/showPdf?pii=S0039-6060%2814%2900786-7).

Newell DJ. Intention-to-Treat Analysis: Implications for Quantitative and Qualitative Research, International Journal of Epidemiology 1992-10-01; 21(5): 837–841. DOI: 10.1093/ije/21.5.837. Available in [pdf format](https://academic.oup.com/ije/article-pdf/21/5/837/1815113/21-5-837.pdf).

Homer, CS. Using the Zelen design in randomized controlled trials: debates and controversies. Journal of Advanced Nursing 2002-04-18; 38: 200-207. doi:10.1046/j.1365-2648.2002.02164.x.

Brainard, J., Wilsher, S.H., Salter, C. et al. Methodological review: quality of randomized controlled trials in health literacy. BMC Health Serv Res 16, 246 (2016). https://doi.org/10.1186/s12913-016-1479-2. Available in [html format](https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-016-1479-2) or [pdf format](https://bmchealthservres.biomedcentral.com/track/pdf/10.1186/s12913-016-1479-2).

Kypria K, Bowe SJ, Karlsson N, McCambridge J. Enrolment-latency in randomized behavior change trials: individual participant data meta-analysis showed association with attrition but not effect-size. doi: 10.1016/j.jclinepi.2019.09.019.

Harris AD, McGregor JC, Perencevich EN, Furuno JP, Zhu J, Peterson DE, Finkelstein J. The Use and Interpretation of Quasi-Experimental Studies in Medical Informatics, Journal of the American Medical Informatics Association 2006-01-01l 13(1), 16–23. doi: 10.1197/jamia.M1749. Available in [html format](https://academic.oup.com/jamia/article/13/1/16/780729) or [pdf format](https://academic.oup.com/jamia/article-pdf/13/1/16/17373511/13-1-16.pdf).